Tasly Pharmaceutical Group Co., Ltd.

Tianjin Tasly Pharmaceutical Co., Ltd.

Tianjin Tasly Pharmaceutical Co., Ltd., China

Dekun Li

Feng Wei

Zhengliang Ye

Chongnian Luo

Ying Zhao

Yonghong Zhu

Jianming Chen

Jun Gao

XiaoLi Zheng

GuangMing Zhang

JunFeng Xiong

Hongshui Yue

Zhijuan Huang

Jiangxiao Sun

Qingchuang Chen

Xiaoli Zheng

Guangming Zhang

The present invention relates to plant extracts, specifically, the extracts of Chinese medicineL. and the composition comprising thereof. The extracts of Chinese medicineL. are prepared by conventional methods for the extraction of volatile oil, and can be used to treat-induced diseases of digestive system, such as gastritis, gastric ulcer, etc., with easy availability of raw materials, simple preparations, prominent effects, and less side-effect.

[object Object]

The present invention relates to plant extracts, specifically, the extracts of Chinese medicine. and the composition comprising thereof. The extracts of Chinese medicine. are prepared by conventional methods for the extraction of volatile oil, and can be used to treat-induced diseases of digestive system, such as gastritis, gastric ulcer, etc., with easy availability of raw materials, simple preparations, prominent effects, and less side-effect.

A process for preparing tanshintotalphenolic acid and the use of the product are disclosed. The process comprises: tanshin is hot-extracted with water, the extract is separated and refined by polyamide column and macroporous adsorption resin column, and lyophilized to obtain tanshintotalphenolic acid. The yield of the final end product is more than 4 percent based on the amount of crude drug and the content of totalphenolic acid is more than 80 percent. The tanshintotalphenolic acid obtained can be used as the medicine for preventing and treating cerebrovascular and cardiovascular diseases and so on.

Preparation and application of transhintotalphenolic acid

The present invention discloses a pharmaceutical composition for the treatment of cardiovascular and cerebrovascular diseases which comprises Radix Salviae Miltiorrhizae extract 5.0%-70.0%, Radix Notoginseng extract 10.0%-85.0%, Radix Astragali extract 5.0%-70.0%, and Bomeol or oil of Lignum Dalbergiae Odoriferae 1.0%-15.0%. The composition is active against cerebral ischemia and myocardial ischemia. The effects are superior to total phenic acid of Radix Salviae Miltiorrhizae or total saponin of Radix Notoginseng respectively, or the combination thereof. The composition of the invention can provide various kinds of preparations by the addition of various accessories. Thus the invention provides a more effective and convenient composition of TCM effective sections and its preparations.

Pharmaceutical composition for the treatment of cardiovascular and cerebrovascular diseases

Growing community of inventors

Tianjin, China

Dekun Li